| 2024-12-26 | Borderline leprosy | 0:00 | 2 | |
|
| 2024-12-26 | Lepra reaction | 0:00 | 0 | |
|
| 2024-12-26 | Skin rashes - 1 to 6 disease | 0:00 | 3 | |
|
| 2024-12-26 | Allergic contact dermatitis | 0:00 | 1 | |
|
| 2024-12-25 | Borderline leprosy part 2 | 0:00 | 4 | |
|
| 2024-12-25 | Alopecia areata explained! | 0:00 | 1 | |
|
| 2024-12-25 | Vesiculobullous disorders - classification | 0:00 | 0 | |
|
| 2024-12-25 | Borderline tuberculoid | 0:00 | 4 | |
|
| 2024-12-25 | Acne vulgaris - part 3 | 0:00 | 0 | |
|
| 2024-12-25 | Ridley Jopling leprosy classification | 0:00 | 6 | |
|
| 2024-12-24 | Streptococcus lesions of skin | 0:00 | 1 | |
|
| 2024-12-24 | Cutaneous TB - Management | 0:00 | 1 | |
|
| 2024-12-24 | Syphilis | 0:00 | 0 | |
|
| 2024-12-24 | Lichen planus | 0:00 | 0 | |
|
| 2024-12-24 | Koebner phenomenon | 0:00 | 4 | |
|
| 2024-12-24 | Layers of epidermis | 0:00 | 0 | |
|
| 2024-12-24 | Pemphigous vulgaris vs bullous pemphigoid | 0:00 | 2 | |
|
| 2024-12-24 | Streptococcus lesions of skin - part 2 | 0:00 | 1 | |
|
| 2024-12-23 | Localisation of human genes | 0:00 | 0 | |
|
| 2024-12-23 | Acne vulgaris | 0:00 | 0 | |
|
| 2024-12-23 | Localisation of human genes - part 2 | 0:00 | 0 | |
|
| 2024-12-23 | TEN - Toxic epidermal necrolysis | 0:00 | 1 | |
|
| 2024-12-23 | Fox fordyce disease | 0:00 | 0 | |
|
| 2024-12-23 | Secondary skin lesions | 0:00 | 1 | |
|
| 2024-12-23 | Hair cycle | 0:00 | 1 | |
|
| 2024-12-23 | Steven Johnson syndrome | 0:00 | 2 | |
|
| 2024-12-22 | Woods lamp examination | 0:00 | 3 | |
|
| 2024-12-22 | Classical vs neonatal scabies | 0:00 | 2 | |
|
| 2024-12-22 | Fordyce apots | 0:00 | 2 | |
|
| 2024-12-22 | Types of collagen - part 2 | 0:00 | 0 | |
|
| 2024-12-22 | Acne vulgaris | 0:00 | 0 | |
|
| 2024-12-20 | Erythema Multiforme | 0:00 | 1 | |
|
| 2024-12-19 | Tzanch smear - Cytological findings | 0:00 | 1 | |
|
| 2024-12-19 | Color of skin | 0:00 | 0 | |
|
| 2024-12-19 | Lichen nitidus | 0:00 | 0 | |
|
| 2024-12-19 | Ribosomal assembly in prokaryotes | 0:00 | 0 | |
|
| 2024-12-19 | Lichen planus | 0:00 | 0 | |
|
| 2024-12-19 | Dermoepidermal junction aka basement membrane zone | 0:00 | 4 | |
|
| 2024-12-19 | Psoriasis signs | 0:00 | 1 | |
|
| 2024-12-18 | Bullous pemphigoid | 0:00 | 0 | |
|
| 2024-12-18 | Blistering skin disease | 0:00 | 0 | |
|
| 2024-12-18 | Lupus erythematosus types | 0:00 | 2 | |
|
| 2024-12-18 | Enteroviral diseases | 0:00 | 2 | |
|
| 2024-12-18 | Hailey hailey disease | 0:00 | 2 | |
|
| 2024-12-18 | Molluscum contagious | 0:00 | 3 | |
|
| 2024-12-18 | Skin manifestations of diabetes mellitus | 0:00 | 1 | |
|
| 2024-12-18 | Scabies - part 2 | 0:00 | 1 | |
|
| 2024-12-18 | Immunoflourescence in dermatology | 0:00 | 0 | |
|
| 2024-12-18 | Fixed drug eruptions | 0:00 | 5 | |
|
| 2024-12-18 | Psoriatic nails vs oncomycosis | 0:00 | 0 | |
|
| 2024-12-17 | Pemphigus versicolor | 0:00 | 2 | |
|
| 2024-12-17 | Chancroid | 0:00 | 1 | |
|
| 2024-12-17 | Darriers disease | 0:00 | 0 | |
|
| 2024-12-17 | Epidermolysis bullosa | 0:00 | 1 | |
|
| 2024-12-17 | Donovanosis | 0:00 | 1 | |
|
| 2024-12-17 | Infantile hemangioma | 0:00 | 2 | |
|
| 2024-12-17 | Trichotillomania | 0:00 | 0 | |
|
| 2024-12-17 | Congenital prenatal syphilis | 0:00 | 1 | |
|
| 2024-12-17 | Erythematosus multiforme | 0:00 | 2 | |
|
| 2024-12-17 | Pemphigus vulgaris | 0:00 | 1 | |
|
| 2024-12-17 | Urticaria | 0:00 | 1 | |
|
| 2024-12-17 | Chromoblastomycosis | 0:00 | 2 | |
|
| 2024-12-16 | Scabies | 0:00 | 3 | |
|
| 2024-12-16 | Late congenital syphilis - clinical features | 0:00 | 1 | |
|
| 2024-12-16 | Ichthyosis | 0:00 | 1 | |
|
| 2024-12-16 | Special lesions | 0:00 | 2 | |
|
| 2024-12-16 | Lymphogranuloma venerum | 0:00 | 0 | |
|
| 2024-12-16 | COX 1 | 0:00 | 0 | |
|
| 2024-12-16 | Pemphigus folaceous | 0:00 | 2 | |
|
| 2024-12-16 | Xeroderma pigmentosa | 0:00 | 3 | |
|
| 2024-12-16 | Dermatitis herpetiformis | 0:00 | 0 | |
|
| 2024-12-15 | Lymphatic structures of pelvic structures | 0:00 | 0 | |
|
| 2024-12-15 | Sporotrichosis | 0:00 | 2 | |
|
| 2024-12-15 | Congenital ichthyosis | 0:00 | 2 | |
|
| 2024-12-15 | Distribution of coronary artery | 0:00 | 0 | |
|
| 2024-12-13 | Pyoderma gangrenosum | 0:00 | 2 | |
|
| 2024-12-13 | Lupus erythematosus | 0:00 | 3 | |
|
| 2024-12-13 | Beta oxidation of fatty acids | 0:00 | 0 | |
|
| 2024-12-13 | Gluteal region - Muscles | 0:00 | 0 | |
|
| 2024-12-13 | Ketogenesis | 0:00 | 0 | |
|
| 2024-12-13 | Structures passing through skull foramen - part 2 | 0:00 | 0 | |
|
| 2024-12-13 | Behcets disease | 0:00 | 0 | |
|
| 2024-12-13 | Dermatomyositis | 0:00 | 5 | |
|
| 2024-12-13 | Acanthosis nigricans | 0:00 | 3 | |
|
| 2024-12-13 | Biosynthesis of fatty acids | 0:00 | 0 | |
|
| 2024-12-12 | Prolactin - part 2 | 0:00 | 0 | |
|
| 2024-12-12 | Structures passing through skull foramen | 0:00 | 1 | |
|
| 2024-12-12 | Therapeutic drug monitoring - Part 3 | 0:00 | 0 | |
|
| 2024-12-12 | Phase 2 reaction - part 2 | 0:00 | 0 | |
|
| 2024-12-12 | Chancroid | 0:00 | 2 | |
|
| 2024-12-12 | Lichen planus - Part 2 | 0:00 | 1 | |
|
| 2024-12-12 | Factors inhibiting insulin secretion | 0:00 | 0 | |
|
| 2024-12-12 | SLGT and GLUT transporter | 0:00 | 1 | |
|
| 2024-12-12 | LGV - Lymphogranuloma vengeful | 0:00 | 2 | |
|
| 2024-12-12 | Dialyzable drugs - part 2 | 0:00 | 0 | |
|
| 2024-12-12 | Alopecia areata - part 2 | 0:00 | 2 | |
|
| 2024-12-12 | Tissue stem cells and location | 0:00 | 0 | |
|
| 2024-12-12 | Drugs in therapeutic drug monitoring - part 2 | 0:00 | 0 | |
|
| 2024-12-12 | Factors increasing insulin secretion | 0:00 | 0 | |
|
| 2024-12-11 | Physiological changes in aging - part 1 | 0:00 | 0 | |
|
